文献速递技术与安全PETMR

[68Ga]Ga-Pentixafor PET/MRI 用于慢性淋巴细胞白血病 CXCR4 成像的初步结果

[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.
PubMed 文献 · Invest Radiol · 2018-01-01

这项前瞻性原理验证研究纳入 13 例慢性淋巴细胞白血病患者和 20 例无骨髓浸润的肿瘤对照(10 例胰腺腺癌、10 例黏膜相关淋巴组织淋巴瘤),行[68Ga]Ga-Pentixafor PET/MRI,结果显示 CLL 患者骨盆和 L4 椎体骨髓的 SUVmax、SUVmean 显著高于对照组,骨盆 ADC 值与血清学参数无显著相关,作者认为该显像可能有助于基于 CXCR4 的 CLL 成像。

要点

  • CLL 患者骨髓[68Ga]Ga-Pentixafor 摄取高于无骨髓浸润的肿瘤对照。
  • 鉴别 CLL 与对照的最佳指标为摄取最高病灶的 SUVmax(AUC 0.94)。
  • L4 椎体 SUVmax 的 AUC 为 0.92,鉴别效能亦较高。

核心结论

  • 作者认为[68Ga]Ga-Pentixafor PET/MRI 可能有助于基于 CXCR4 的 CLL 成像。

研究设计与样本

  • 前瞻性原理验证研究,纳入 13 例 CLL 患者和 20 例组织学证实无骨髓浸润的肿瘤对照(10 例胰腺腺癌、10 例黏膜相关淋巴组织淋巴瘤),行[68Ga]Ga-Pentixafor PET/MRI 并测量骨髓摄取与骨盆 ADC 值。

关键影像表现/征象

  • CLL 与胰腺腺癌相比,骨盆骨髓 SUVmax 和 SUVmean 差异有统计学意义(P=0.032 和 P=0.008),L4 椎体两者差异均有统计学意义(均 P<0.001)。
  • CLL 与黏膜相关淋巴组织淋巴瘤相比,骨盆 SUVmean(P=0.020)和 L4 SUVmean(P=0.041)差异有统计学意义,L4 SUVmax(P=0.019)差异亦有统计学意义。
  • 以视觉摄取最高的骨结构 SUVmax 鉴别 CLL 与对照组的 ROC 曲线下面积最大(0.94),L4 椎体 SUVmax 的 AUC 为 0.92。

诊断标准与关键数值

  • 鉴别 CLL 与对照组的 ROC 曲线下面积:摄取最高骨结构 SUVmax 为 0.94,L4 椎体 SUVmax 为 0.92。
  • CLL 与胰腺腺癌比较:骨盆 SUVmax P=0.032、SUVmean P=0.008;L4 椎体 SUVmax 和 SUVmean 均 P<0.001。
  • CLL 与黏膜相关淋巴组织淋巴瘤比较:骨盆 SUVmean P=0.020、L4 SUVmean P=0.041、L4 SUVmax P=0.019。

临床应用与阅片要点

  • 作者认为[68Ga]Ga-Pentixafor PET/MRI 可能有助于基于 CXCR4 的 CLL 成像。
  • 骨髓[68Ga]Ga-Pentixafor 摄取与骨盆 ADC 值及血清学参数无显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This prospective proof-of-principle study aimed to determine whether [Ga]Ga-Pentixafor uptake, which reflects CXCR4 expression, is higher in the bone marrow of chronic lymphocytic leukemia (CLL) than in other oncological diseases without bone marrow infiltration and can therefore be used for CLL imaging.

MATERIALS AND METHODS: Thirteen CLL patients and 20 controls (10 with pancreatic adenocarcinoma and 10 with mucosa-associated lymphoid tissue lymphoma) with histologically proven cancer underwent [Ga]Ga-Pentixafor positron emission tomography/magnetic resonance imaging. Standardized [Ga]Ga-Pentixafor uptake values (SUVmax, SUVmean) were measured in the bone marrow of the pelvis, the lumbar vertebra L4, and the bony structure with the visually highest tracer uptake ("hottest lesion"). Mean apparent diffusion coefficient values were also measured in the pelvis. Serum leukocyte count (gram per liter), lymphocyte percentage (percent), lactate dehydrogenase (unit per liter), β2-microglobulin (milligram per deciliter), and C-reactive protein (milligram per deciliter) were measured. Statistical analyses comprised analysis of variance with Games-Howell post hoc tests and Spearman correlation coefficients.

RESULTS: SUVmax and SUVmean differed significantly between CLL and pancreatic adenocarcinoma in the pelvis (P = 0.032 and P = 0.008) and lumbar vertebra L4 (both P < 0.001). SUVmean also differed in the pelvis (P = 0.020) and L4 (P = 0.041), and SUVmax in L4 (P = 0.019), between CLL and mucosa-associated lymphoid tissue lymphoma. Receiver operating characteristic-based areas under the curve for separation of CLL from the control groups were greatest for the SUVmax of the bony structure with the strongest [Ga]Ga-Pentixafor uptake (0.94) and the SUVmax of L4 (0.92). There was no significant correlation between [Ga]Ga-Pentixafor uptake and pelvic apparent diffusion coefficients or serum parameters.

CONCLUSIONS: [Ga]Ga-Pentixafor positron emission tomography/magnetic resonance imaging may possibly be useful for CXCR4-based CLL imaging.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Mayerhoefer ME, Jaeger U, Staber P, et al. [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results. Invest Radiol. 2018. PMID: 29642081. doi:10.1097/RLI.0000000000000469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。